Open-label Extension Study of AbobotulinumtoxinA (Dysport®) for the Treatment of Cervical Dystonia
Public ClinicalTrials.gov record NCT00288509. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III, Prospective, Multicenter, Open-label Extension Study to Assess the Longer Term Safety and Efficacy of Repeated Treatment of Dysport® Intramuscular Injection in the Treatment of Cervical Dystonia
Study identification
- NCT ID
- NCT00288509
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Ipsen
- Industry
- Enrollment
- 108 participants
Conditions and interventions
Conditions
Interventions
- Botulinum toxin type A Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2006
- Primary completion
- Dec 31, 2007
- Completion
- Dec 31, 2007
- Last update posted
- Sep 27, 2022
2006 – 2008
United States locations
- U.S. sites
- 14
- U.S. states
- 9
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Barrow Neurology Clinics at St. Joseph's Hospital and Medical Center | Phoenix | Arizona | 85013 | — |
| The Parkinson's and Movement Disorder Institute | Fountain Valley | California | 92708 | — |
| USC School of Medicine | Los Angeles | California | 90033 | — |
| University of Florida, Dept of Neurology | Gainesville | Florida | 32610 | — |
| University of Miami, Dept of Neurology | Miami | Florida | 33136 | — |
| Emory University School of Medicine, Wesley Woods Health Center | Atlanta | Georgia | 30329 | — |
| University of Iowa, Dept of Neurology | Iowa City | Iowa | 52242 | — |
| Wayne State University Medical Center | Southfield | Michigan | 48034 | — |
| Albany Medical Center | Albany | New York | 12205 | — |
| Beth Israel Medical Center | New York | New York | 10003 | — |
| Columbia University Medical Center, Neurological Institute | New York | New York | 10032 | — |
| Allegheny General Hospital | Pittsburgh | Pennsylvania | 15212 | — |
| University of Texas Southwest Medical Center, Movement Disorder Clinic | Dallas | Texas | 75309 | — |
| Baylor College of Medicine, Parkinson's Disease Center and Movement Disorders Clinic | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00288509, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 27, 2022 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00288509 live on ClinicalTrials.gov.